Fluicell

14.25 SEK

+6.34 %

Less than 1K followers

FLUI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+6.34 %
+31.94 %
+71.69 %
+42.50 %
+10.47 %
+16.42 %
-93.50 %
-99.38 %
-98.71 %

Fluicell operates in biotechnology. The company conducts research and development in the processing of cell composition in the development of new drugs. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and ultimately process cells. In addition, there is expertise in 2D/3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.

Read more
Market cap
19.58M SEK
Turnover
54.75K SEK
Revenue
6M
EBIT %
-139.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
8/5
2026

Interim report Q1'26

3/6
2026

General meeting '26

14/8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.